Regeneron Pharmaceuticals
Utility Patents
Last updated:
List of all Regeneron Pharmaceuticals patents 248 in total
| Status | Patent |
|---|---|
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Inducible eukaryotic expression system Filling date: 12 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Human antibodies to influenza hemagglutinin Filling date: 12 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells Filling date: 12 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor Filling date: 12 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor Filling date: 12 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Compositions and methods for detecting a biological contaminant Filling date: 12 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Methods for tumor treatment using CD3XCD20 bispecific antibody Filling date: 12 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Nucleic acid molecules encoding antibodies to the human glucagon receptor Filling date: 12 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: Anti-IL-25 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: Mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: Anti-ErbB3 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Anti-C5 antibodies Filling date: 12 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Nuclease-mediated DNA assembly Filling date: 12 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR Filling date: 12 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: B cell lineage based immunogen design with humanized animals Filling date: 12 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Purification platform for bispecific antibodies Filling date: 12 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Antigen-binding proteins that activate the leptin receptor Filling date: 12 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Production cell line enhancers Filling date: 12 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Methods and systems for chromatography data analysis Filling date: 12 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Isolating cells expressing secreted proteins Filling date: 12 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Humanized IL-4 and IL-4R.alpha. animals Filling date: 12 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders Filling date: 12 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Nucleic acids encoding high affinity antibodies to human IL-6 receptor Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Non-human animals having an engineered ANGPTL8 gene Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Biologically active molecules, conjugates thereof, and therapeutic uses Filling date: 12 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: GPR156 variants and uses thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Humanized IL-15 animals Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Humanized light chain mice Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Non-human animals having humanized Fc-gamma receptors Filling date: 12 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Heavy chain constant regions with reduced binding to Fc gamma receptors Filling date: 12 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Antigen-binding proteins that antagonize leptin receptor Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Methods and antibody compositions for tumor treatment Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Humanized non-human animals with restricted immunoglobulin heavy chain loci Filling date: 12 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Filling date: 12 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Conditional rodent Acvr1 mutant gene Filling date: 12 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody Filling date: 12 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Angiopoietin-based interventions for treating cerebral malaria Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Humanized C3 animals Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Anti-activin A antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Amino acid acylation reagents and methods of using the same Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Genetically modified mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Nucleic acids encoding IL-33 antibodies Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Multimeric protein purity determination Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Anti-FGFR1c antibody-FGF21 fusion proteins Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Showing 150 to 200 of 248 patents.